m peregrinum quality control qc reference strain atcc 700686 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
95
Structured Review
ATCC
m peregrinum quality control qc reference strain atcc 700686
M Peregrinum Quality Control Qc Reference Strain Atcc 700686, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 152 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qc+reference+strains/Mycobacterium+peregrinum/pm39808861-46-1-8
Average 95 stars, based on 152 article reviews
M Peregrinum Quality Control Qc Reference Strain Atcc 700686, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 152 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qc+reference+strains/Mycobacterium+peregrinum/pm39808861-46-1-8
Average 95 stars, based on 152 article reviews
m peregrinum quality control qc reference strain atcc 700686 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
other:Article Title: Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method Article Snippet: However, MIC data were not included in the pooled distributions used for the calculation of ECVs unless the data for Article Title: Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method. Article Snippet: Quality assurance was performed by concurrent testing of CLSIrecommended Control:Article Title: Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015). Article Snippet: Accepted Manuscript Title: Activity of Dalbavancin Tested against Gram-Positive Clinical Isolates Causing Skin and Skin Structure Infections in Paediatric Patients from US Hospitals (2014 − 2015).. Authors: Michael A. Pfaller, Rodrigo E. Mendes, Helio S. Sader, Mariana Castanheira, Robert K. Flamm PII: S2213-7165(17)30115-7 DOI: http://dx.doi.org/doi:10.1016/j.jgar.2017.06.003 Reference: JGAR 439 To appear in: Received date: 7-3-2017 Revised date: 1-6-2017 Accepted date: 2-6-2017 Please cite this article as: Michael A.Pfaller, Rodrigo E.Mendes, Helio S.Sader, Mariana Castanheira, Robert K.Flamm, Activity of Dalbavancin Tested against Gram-Positive Clinical Isolates Causing Skin and Skin Structure Infections in Paediatric Patients from US Hospitals (2014 − 2015). (2010), http://dx.doi.org/10.1016/j.jgar.2017.06.003 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. Article Title: Antimicrobial activity of dalbavancin against clinical isolates of coagulase-negative staphylococci from the USA and Europe stratified by species. Article Snippet: Testing was performed using reference 96-well panels manufactured by JMI Laboratories (North Liberty, Iowa, US). .. Quality control (QC) was performed by concurrent testing of Article Title: WGS Analysis of Staphylococcus warneri Outbreak in a Neonatal Intensive Care Unit Article Snippet: Positive cultures were identified as S. warneri using a microflex LT/SH smart MALDI-TOF MS system (Bruker Daltonik, Bremen, Germany) and Vitek GP, Vitek2 automated system (bioMérieaux, Paris, France)., Drug susceptibility testing was determined using the VITEK 2 automated system. .. Quality control (QC) was performed by Clinical and Laboratory Standards Institute (CLSI) recommended QC Biomarker Discovery:Article Title: Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) as Determined by the Revised Susceptibility Testing Method Article Snippet: .. Validation 86 of the MIC values was performed by concurrent testing of CLSI‐recommended Article Title: Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) as Determined by the Revised Susceptibility Testing Method Article Snippet: .. Validation of the MIC values was performed by concurrent testing of |